Literature DB >> 9032094

Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1.

T Brun1, F Assimacopoulos-Jeannet, B E Corkey, M Prentki.   

Abstract

The mechanism whereby long-term exposure of the beta-cell to fatty acids alters the beta-cell response to glucose is not known. We hypothesized that fatty acids may alter beta-cell function by changing the expression level of metabolic enzymes implicated in the regulation of insulin secretion, in particular acetyl-CoA carboxylase (ACC). This enzyme catalyzes the formation of malonyl-CoA, a key regulator of fatty acid oxidation. Using the beta-cell line INS-1 as a model, the results show that the polyunsaturated fatty acid linoleate (C18:2) inhibited both basal and glucose-stimulated ACC mRNA induction. The inhibition was detected by 4-6 h, and a maximal 60% effect occurred at 12 h after cell exposure to the fatty acid. Linoleate, as glucose, did not modify the half-life of the ACC transcript. Prolonged exposure of INS-1 cells to linoleate also inhibited ACC protein accumulation at low and high glucose. The saturated fatty acids myristate (C14:0), palmitate (C16:0), and stearate (C18:0) were also effective as well as the monounsaturated oleate (C18:1) and the short-chain fatty acids butyrate (C4:0) and caproate (C6:0); long-chain omega3 fatty acids were ineffective. The threshold concentration for long-chain fatty acids was 0.05 mmol/l, and maximal inhibition occurred at 0.3 mmol/l. 2-bromopalmitate, a nonmetabolizable analog, had no effect, suggesting that fatty acids must be metabolized to change ACC gene expression. Prolonged exposure of INS-1 cells to palmitate, oleate, and linoleate markedly altered the glucose-induced insulin response, resulting in high basal insulin release and a suppression of glucose-induced insulin secretion. This was associated with an exaggerated (twofold to threefold) rate of fatty acid oxidation at all tested glucose concentrations. The data provide a possible mechanism to at least partially explain how fatty acids cause beta-cell insensitivity to glucose, i.e., by downregulating ACC with a resulting exaggerated fatty acid oxidation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032094     DOI: 10.2337/diab.46.3.393

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

Review 1.  The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function.

Authors:  V A Zammit
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

2.  Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain.

Authors:  Hyung-Wook Kim; Jagadeesh S Rao; Stanley I Rapoport; Miki Igarashi
Journal:  Biochim Biophys Acta       Date:  2010-11-09

3.  Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans.

Authors:  C Xiao; A Giacca; A Carpentier; G F Lewis
Journal:  Diabetologia       Date:  2006-04-05       Impact factor: 10.122

4.  Fatty acids and beta-cell function.

Authors:  A Björklund; G Yaney; J D McGarry; G Weir
Journal:  Diabetologia       Date:  1997-10       Impact factor: 10.122

Review 5.  Polyunsaturated fatty acid regulation of gene expression.

Authors:  J M Ntambi; H Bené
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

6.  Peroxisome proliferator-activated receptor alpha (PPARalpha) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism.

Authors:  F Frigerio; T Brun; C Bartley; A Usardi; D Bosco; K Ravnskjaer; S Mandrup; P Maechler
Journal:  Diabetologia       Date:  2009-11-12       Impact factor: 10.122

7.  24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury.

Authors:  Casandra M Cartagena; Mark P Burns; G William Rebeck
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252

8.  Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acids.

Authors:  Paul S Phillips; Theodore P Ciaraldi; Dong-Lim Kim; M Anthony Verity; Tanya Wolfson; Robert R Henry
Journal:  Endocrine       Date:  2008-12-03       Impact factor: 3.633

9.  Stevioside Counteracts Beta-Cell Lipotoxicity without Affecting Acetyl CoA Carboxylase.

Authors:  Jianguo Chen; Per Bendix Jeppesen; Iver Nordentoft; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2007-02-10

10.  Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1.

Authors:  I Rakatzi; H Mueller; O Ritzeler; N Tennagels; J Eckel
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.